Survival after cardiopulmonary arrest in a tertiary care hospital in Turkey.
Sinan Yilmaz, Imran Kurt Omurlu
https://pubmed.ncbi.nlm.nih.gov/30905924Actively Recruiting
Phase Not Applicable
Age: 55Years +
All Genders
ID07184541
The Effect of a Nurse-led Daily Weight Monitoring Intervention (Wake and Weigh) on Heart Failure Quality of Life and Self-care
Led by Lee Anne Siegmund · Updated on 2025-09-24
42
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating a nurse-led daily weight monitoring tool called Wake and Weigh to improve self-care and quality of life in older adults with heart failure. This pilot randomized controlled trial aims to test the feasibility and methods for a larger future study. The study focuses on adults aged 55 and older hospitalized with heart failure, addressing the challenges patients face with complicated self-care instructions and activity limitations. Participants are randomized to either use the Wake and Weigh tool along with usual care or receive usual care alone, which includes a heart failure handbook. The tool helps patients track their weight daily during hospitalization and after discharge, with nurse education and encouragement for consistent use. Patients record their weight each morning, using the same scale, and report significant weight changes to their healthcare provider. Follow-up calls occur at 2 weeks (intervention group) and 4 weeks (both groups) after discharge to assess tool use and health outcomes. During the study, participants complete surveys measuring heart failure self-care and quality of life at admission and 4 weeks post-discharge. Nurse investigators monitor the intervention's delivery and patient use of the tool. Data collection includes hospital and follow-up visits, survey completion rates, and patient feedback on confidence and tool usefulness. The study lasts from hospital admission through 4 weeks after discharge, assessing feasibility, recruitment, retention, and appropriateness of the measurement tools.
CONDITIONS
Brief Title
A Nurse-Led Weight Monitoring Intervention For Heart Failure Quality of LIfe and Self-Care
Who Can Participate
Age: 55Years +
All Genders
Eligibility Criteria
You may qualify if you...
- Adults 55 years or older
- New or existing diagnosis of heart failure
- Currently treated for heart failure signs or symptoms during this hospital stay (such as IV diuretics, fluid restriction, or low sodium diet)
- Able to read and communicate in English
- Able to stand and weigh independently
- Have a scale at home or ability to obtain one for the study
You will not qualify if you...
- Documented diagnosis of cognitive impairment
- Charlson Comorbidity Index (CCI) greater than 4, indicating higher risk of longer hospital stays
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Inpatient Treatment
Duration - Duration of hospital stay
Participants admitted to the hospital with heart failure receive education on daily weight monitoring using the Wake and Weigh tool (intervention group) or usual care education with a heart failure handbook (control group). Nurses provide daily reinforcement of the intervention during hospitalization.
Daily interactions with nurse investigators during hospital stay
Outpatient Treatment
Duration - Up to 4 weeks post-discharge
After discharge, participants are instructed to continue daily weight monitoring using the Wake and Weigh tool (intervention group) or usual care practices (control group) at home.
Follow-up phone calls at 2 weeks (intervention group only) and 4 weeks after discharge (both groups)
Trial Site Locations
Total: 1 location
1
Cleveland Clinic Avon Hospital
Avon, Ohio, United States, 44011
Actively Recruiting
Loading map...
Research Team
L
Lee Anne Siegmund, PhD, RN
K
Kelli Falbo, MSN, RN
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association.
Salim S Virani, Alvaro Alonso, Hugo J Aparicio...
https://pubmed.ncbi.nlm.nih.gov/33501848Development and Validation of a Short Version of the Kansas City Cardiomyopathy Questionnaire.
John A Spertus, Philip G Jones
https://pubmed.ncbi.nlm.nih.gov/26307129Using Technology to Enhance Discharge Teaching and Improve Coping for Patients After Stroke.
Melissa A Schneider, Katrina A Howard
https://pubmed.ncbi.nlm.nih.gov/28346312A middle-range theory of self-care of chronic illness.
Barbara Riegel, Tiny Jaarsma, Anna Strömberg
https://pubmed.ncbi.nlm.nih.gov/22739426Psychometric Testing of the Revised Self-Care of Heart Failure Index.
Barbara Riegel, Claudio Barbaranelli, Beverly Carlson...
https://pubmed.ncbi.nlm.nih.gov/30303894Symptom perceptions and self-care behaviors in patients who self-manage heart failure.
Katherine M Reeder, Patrick M Ercole, Gina M Peek...
https://pubmed.ncbi.nlm.nih.gov/24335834Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.
Hude Quan, Vijaya Sundararajan, Patricia Halfon...
https://pubmed.ncbi.nlm.nih.gov/16224307Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries.
Hude Quan, Bing Li, Chantal M Couris...
https://pubmed.ncbi.nlm.nih.gov/21330339Symptom Diary Use and Improved Survival for Patients With Heart Failure.
Linda G Park, Kathleen Dracup, Mary A Whooley...
https://pubmed.ncbi.nlm.nih.gov/29158435